title: [How should Norwegian drug cost policy be structured?].
authors.forename: Vidar
authors.initials: V
authors.lastname: Sie
authors.forename: Grethe
authors.initials: G
authors.lastname: Aasved
authors.forename: Hallstein
authors.initials: H
authors.lastname: Husbyn
authors.forename: Christian
authors.initials: C
authors.lastname: Clemm
authors.forename: Håvard Selby
authors.initials: HS
authors.lastname: Ebbestad
authors.forename: Anders
authors.initials: A
authors.lastname: Tullgren
mesh_terms: D016527:Drug Costs; D004345:Drug Industry / Q000191:economics; D016568:Drugs, Generic / Q000191:economics; D006291:Health Policy; D006801:Humans; D009664:Norway
chemical_list: D016568:Drugs, Generic